Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Some extracts from the Cohen Report

Deb,

I would have to agree with you about the way Cohen has evaluated the MMP. I also share in your excitement of the potential of Crossflo.

Cohen seems to be basing their forcast on what the MMP has brought in to date.

This could all change with the USPTO recertification of the 148 and 336 patents and could provide much better numbers from the MMP in the future. Anyone that thinks they know the MMP is dead before the USPTO has ruled on the 148 and 336 is dreaming.

What's good to see is that PTSC is becoming somthing beyond the MMP. Most of us got into this stock solely based on the potential of the MMP. The Cohen report provides some guidance as to where PTSC is headed but what is exciting is that the potential for the MMP is still there and potentially a big boost, if recertified, to the projections provided by Cohen as I believe like many here that the recertification of the patents will provide some real teeth to go after the remaining infringers for more money.

I remain long and patient.

All the best,

Steve



Share
New Message
Please login to post a reply